Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Neurology|August 29, 2023
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: LaurietCecilia Monteiro, Balazs Toth, Flavia Brunstein, et al.
Pediatric Pulmonology|November 29, 2021
Surfactant protein D is a biomarker of influenza-related pediatric lung injuryArindam Chakrabarti, Allen Nguyen, Margaret M Newhams, et al.
Frontiers in Neurology|March 6, 2023
SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumabJeffrey L Bennett, Kazuo Fujihara, Ho Jin Kim, et al.
Elife|November 14, 2015
A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cellsBenjamin G Gowen, Bryan Chim, Caleb D Marceau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 29, 2026
Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's diseaseJulie Lee, Emily Olafson, Balazs Toth, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
The SP140-RESIST pathway regulates interferon mRNA stability and antiviral immunityKristen C Witt, Adam Dziulko, Joohyun An, et al.
Nature|June 11, 2025
SP140-RESIST pathway regulates interferon mRNA stability and antiviral immunityKristen C Witt, Adam Dziulko, Joohyun An, et al.
Molecular Cell|August 18, 2018
An Mtb-Human Protein-Protein Interaction Map Identifies a Switch between Host Antiviral and Antibacterial ResponsesBennett H Penn, Zoe Netter, Jeffrey R Johnson, et al.
JAMA Neurology|March 11, 2024
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne H Cross, Jeffrey M Gelfand, Simon Thebault, et al.
Pageof 6